News >

Debate Continues on Optimal Neoadjuvant Regimen in Resectable Pancreatic Cancer

Brittany Cote
Published: Thursday, Apr 02, 2020

Michael Choti, MD

Michael Choti, MD

Radiation therapy is not an essential component of neoadjuvant therapy for patients with resectable pancreatic cancer, according to Michael A. Choti, MD, MBA, FACS, who added that chemotherapy is the main treatment that should be used.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication